{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T20:55:31Z","timestamp":1773867331161,"version":"3.50.1"},"reference-count":58,"publisher":"Elsevier BV","issue":"14","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T00:00:00Z","timestamp":1720396800000},"content-version":"vor","delay-in-days":7,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004607","name":"Natural Science Foundation of Guangxi Province","doi-asserted-by":"publisher","award":["2020GXNSFAA297156"],"award-info":[{"award-number":["2020GXNSFAA297156"]}],"id":[{"id":"10.13039\/501100004607","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81960797"],"award-info":[{"award-number":["81960797"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heliyon"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/j.heliyon.2024.e34297","type":"journal-article","created":{"date-parts":[[2024,7,10]],"date-time":"2024-07-10T09:25:54Z","timestamp":1720603554000},"page":"e34297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The molecular and network mechanisms of antilipidemic potential effects of Ganfule capsules in nonalcoholic fatty liver disease"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5014-9415","authenticated-orcid":false,"given":"Yu","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liya","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunkun","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suren R.","family":"Sooranna","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danna","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Ou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-4061-244X","authenticated-orcid":false,"given":"Lu","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.heliyon.2024.e34297_bib1","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34297_bib2","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.jhep.2019.06.021","article-title":"The global epidemiology of NAFLD and NASH in patients with type 2 diabetes: a systematic review and meta-analysis","volume":"71","author":"Younossi","year":"2019","journal-title":"J. Hepatol."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34297_bib3","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jhep.2018.05.036","article-title":"Modeling NAFLD disease burden in China, France, Germany, Italy, Japan, Spain, United Kingdom, and United States for the period 2016-2030","volume":"69","author":"Estes","year":"2018","journal-title":"J. Hepatol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34297_bib4","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1002\/hep.28785","article-title":"The economic and clinical burden of nonalcoholic fatty liver disease in the United States and Europe","volume":"64","author":"Younossi","year":"2016","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34297_bib5","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s13020-021-00469-4","article-title":"Traditional Chinese Medicine in nonalcoholic fatty liver disease: molecular insights and therapeutic perspectives","volume":"16","author":"Dai","year":"2021","journal-title":"Chin. Med."},{"key":"10.1016\/j.heliyon.2024.e34297_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejphar.2021.173976","article-title":"Research progress in use of traditional Chinese medicine monomer for treatment of non-alcoholic fatty liver disease","volume":"898","author":"Zhou","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2021.105849","article-title":"Traditional Chinese medicine in the treatment of nonalcoholic steatohepatitis","volume":"172","author":"Chen","year":"2021","journal-title":"Pharmacol. Res."},{"key":"10.1016\/j.heliyon.2024.e34297_bib8","doi-asserted-by":"crossref","first-page":"601","DOI":"10.3389\/fphar.2020.00601","article-title":"Herbal medicine in the treatment of non-alcoholic fatty liver diseases-efficacy, action mechanism, and clinical application","volume":"11","author":"Xu","year":"2020","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.930785","article-title":"Ganfule capsule alleviates bile duct ligation-induced liver fibrosis in mice by inhibiting glutamine metabolism","volume":"13","author":"Ke","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib10","article-title":"Chinese herbal medicine for primary liver cancer therapy: perspectives and challenges","volume":"13","author":"Li","year":"2022","journal-title":"Front. Pharmacol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34297_bib11","doi-asserted-by":"crossref","first-page":"2280","DOI":"10.1111\/jam.15307","article-title":"Effects of Ganfule capsule on microbial and metabolic profiles in anti-hepatocellular carcinoma","volume":"132","author":"Xu","year":"2022","journal-title":"J. Appl. Microbiol."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34297_bib12","first-page":"760","article-title":"Identification of chemical constituents in Ganfule by UPLC-Q-TOF\/MS combined with UNIFI software","volume":"41","author":"Fei","year":"2021","journal-title":"Chin J Pharm Anal (\u836f\u7269\u5206\u6790\u6742\u5fd7)"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34297_bib13","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/nchembio.118","article-title":"Network pharmacology: the next paradigm in drug discovery","volume":"4","author":"Hopkins","year":"2008","journal-title":"Nat. Chem. Biol."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34297_bib14","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.tips.2021.11.004","article-title":"Network pharmacology: curing causal mechanisms instead of treating symptoms","volume":"43","author":"Nogales","year":"2022","journal-title":"Trends Pharmacol. Sci."},{"issue":"18","key":"10.1016\/j.heliyon.2024.e34297_bib15","doi-asserted-by":"crossref","first-page":"4331","DOI":"10.3390\/ijms20184331","article-title":"Molecular docking: shifting paradigms in drug discovery","volume":"20","author":"Pinzi","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"W1","key":"10.1016\/j.heliyon.2024.e34297_bib16","doi-asserted-by":"crossref","first-page":"W356","DOI":"10.1093\/nar\/gkx374","article-title":"PharmMapper 2017 update: a web server for potential drug target identification with a comprehensive target pharmacophore database","volume":"45","author":"Wang","year":"2017","journal-title":"Nucleic Acids Res."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34297_bib17","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.apsb.2021.03.024","article-title":"A comprehensive review of integrative pharmacology-based investigation: a paradigm shift in traditional Chinese medicine","volume":"11","author":"Xu","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34297_bib18","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.1002\/bio.4360","article-title":"Enzyme activity inhibition properties of new cellulose nanocrystals from Citrus medica L. pericarp: a perspective of cholesterol lowering","volume":"37","author":"Kalhori","year":"2022","journal-title":"Luminescence"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34297_bib19","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1080\/07391102.2020.1724568","article-title":"Oil-in-water nanoemulsions comprising Berberine in olive oil: biological activities, binding mechanisms to human serum albumin or holo-transferrin and QMMD simulations","volume":"39","author":"Sharifi-Rad","year":"2021","journal-title":"J. Biomol. Struct. Dyn."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34297_bib20","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/s41598-020-80769-1","article-title":"Automation of absolute protein-ligand binding free energy calculations for docking refinement and compound evaluation","volume":"11","author":"Heinzelmann","year":"2021","journal-title":"Sci. Rep."},{"issue":"1 Suppl","key":"10.1016\/j.heliyon.2024.e34297_bib21","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J. Hepatol."},{"issue":"10","key":"10.1016\/j.heliyon.2024.e34297_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12894","article-title":"Cellular senescence and cancer: focusing on traditional Chinese medicine and natural products","volume":"53","author":"Liu","year":"2020","journal-title":"Cell Prolif."},{"key":"10.1016\/j.heliyon.2024.e34297_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2019.112442","article-title":"Advances in anti hepatic fibrotic therapy with Traditional Chinese Medicine herbal formula","volume":"251","author":"Li","year":"2020","journal-title":"J. Ethnopharmacol."},{"issue":"30","key":"10.1016\/j.heliyon.2024.e34297_bib24","doi-asserted-by":"crossref","first-page":"6890","DOI":"10.3748\/wjg.v22.i30.6890","article-title":"Herbal medicines and nonalcoholic fatty liver disease","volume":"22","author":"Yao","year":"2016","journal-title":"World J. Gastroenterol."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34297_bib25","doi-asserted-by":"crossref","first-page":"3715","DOI":"10.3390\/ijms22073715","article-title":"Beneficial effects of phenolic compounds on gut microbiota and metabolic syndrome","volume":"22","author":"Kasprzak-Drozd","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"8","key":"10.1016\/j.heliyon.2024.e34297_bib26","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1111\/bph.14938","article-title":"Naringenin attenuates non-alcoholic fatty liver disease by down-regulating the NLRP3\/NF-\u03baB pathway in mice","volume":"177","author":"Wang","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib27","article-title":"Luteolin, a flavonoid, as an anticancer agent: a review [published correction appears in Biomed Pharmacother. 2019 Aug;116:109084]","volume":"112","author":"Imran","year":"2019","journal-title":"Biomed. Pharmacother."},{"issue":"5","key":"10.1016\/j.heliyon.2024.e34297_bib28","doi-asserted-by":"crossref","first-page":"2081","DOI":"10.1002\/ptr.7429","article-title":"Anti-inflammatory effect of Rhein on ulcerative colitis via inhibiting PI3K\/Akt\/mTOR signaling pathway and regulating gut microbiota","volume":"36","author":"Dong","year":"2022","journal-title":"Phytother Res."},{"key":"10.1016\/j.heliyon.2024.e34297_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110802","article-title":"Kanglexin, a new anthraquinone compound, attenuates lipid accumulation by activating the AMPK\/SREBP-2\/PCSK9\/LDLR signalling pathway","volume":"133","author":"Li","year":"2021","journal-title":"Biomed. Pharmacother."},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34297_bib30","doi-asserted-by":"crossref","first-page":"336","DOI":"10.4093\/dmj.2019.0042","article-title":"Combination of probiotics and salvia miltiorrhiza polysaccharide alleviates hepatic steatosis via gut microbiota modulation and insulin resistance improvement in high fat-induced NAFLD mice","volume":"44","author":"Wang","year":"2020","journal-title":"Diabetes Metab. J"},{"key":"10.1016\/j.heliyon.2024.e34297_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115457","article-title":"Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis","volume":"296","author":"Ye","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib32","doi-asserted-by":"crossref","DOI":"10.1016\/j.jep.2022.115457","article-title":"Poria cocos polysaccharides rescue pyroptosis-driven gut vascular barrier disruption in order to alleviates non-alcoholic steatohepatitis","volume":"296","author":"Ye","year":"2022","journal-title":"J. Ethnopharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib33","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2022.967623","article-title":"Chaihu Shugan powder alleviates liver inflammation and hepatic steatosis in NAFLD mice: a network pharmacology study and in vivo experimental validation","volume":"13","author":"Lei","year":"2022","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib34","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/j.biopha.2018.03.158","article-title":"Effects of shenling baizhu powder herbal formula on intestinal microbiota in high-fat diet-induced NAFLD rats","volume":"102","author":"Zhang","year":"2018","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e34297_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.108863","article-title":"Yinchenhao decoction suppresses rat liver fibrosis involved in an apoptosis regulation mechanism based on network pharmacology and transcriptomic analysis","volume":"114","author":"Cai","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.heliyon.2024.e34297_bib36","article-title":"Bawei Chenxiang wan ameliorates cardiac hypertrophy by activating AMPK\/PPAR-\u03b1 signaling pathway improving energy metabolism","volume":"12","author":"Zhang","year":"2021","journal-title":"Front. Pharmacol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib37","article-title":"Polydatin, A glycoside of resveratrol, is better than resveratrol in alleviating non-alcoholic fatty liver disease in mice fed a high-fructose diet","volume":"9","author":"Zhao","year":"2022","journal-title":"Front. Nutr."},{"issue":"11","key":"10.1016\/j.heliyon.2024.e34297_bib38","doi-asserted-by":"crossref","first-page":"346","DOI":"10.3390\/biology9110346","article-title":"Lauric acid versus palmitic acid: effects on adipose tissue inflammation, insulin resistance, and non-alcoholic fatty liver disease in obesity","volume":"9","author":"Saraswathi","year":"2020","journal-title":"Biology"},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34297_bib39","doi-asserted-by":"crossref","first-page":"3671","DOI":"10.3390\/ijms22073671","article-title":"Biological properties and prospects for the application of eugenol-A review","volume":"22","author":"Ulanowska","year":"2021","journal-title":"Int. J. Mol. Sci."},{"issue":"7","key":"10.1016\/j.heliyon.2024.e34297_bib40","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1111\/jgh.13272","article-title":"Treatment with geraniol ameliorates methionine-choline-deficient diet-induced non-alcoholic steatohepatitis in rats","volume":"31","author":"Chen","year":"2016","journal-title":"J. Gastroenterol. Hepatol."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34297_bib41","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/ptr.7344","article-title":"Scutellarin ameliorates hepatic lipid accumulation by enhancing autophagy and suppressing IRE1\u03b1\/XBP1 pathway","volume":"36","author":"Zhang","year":"2022","journal-title":"Phytother Res."},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34297_bib42","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.7150\/ijbs.68873","article-title":"Atractylenolide III ameliorates non-alcoholic fatty liver disease by activating hepatic adiponectin receptor 1-mediated AMPK pathway","volume":"18","author":"Li","year":"2022","journal-title":"Int. J. Biol. Sci."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34297_bib43","doi-asserted-by":"crossref","first-page":"206","DOI":"10.3390\/nu13010206","article-title":"Curcumin, quercetin, catechins and metabolic diseases: the role of gut microbiota","volume":"13","author":"Shabbir","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/j.heliyon.2024.e34297_bib44","doi-asserted-by":"crossref","DOI":"10.1007\/978-1-59745-554-1","article-title":"Methods in molecular biology. Therapeutic antibodies. Methods and protocols. Preface","volume":"525","author":"Dimitrov","year":"2009","journal-title":"Methods Mol. Biol."},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34297_bib45","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1501240","article-title":"Regulation of protein-ligand binding affinity by hydrogen bond pairing","volume":"2","author":"Chen","year":"2016","journal-title":"Sci. Adv."},{"issue":"13","key":"10.1016\/j.heliyon.2024.e34297_bib46","doi-asserted-by":"crossref","first-page":"3315","DOI":"10.1021\/acs.jafc.8b00758","article-title":"\u03c0-Cation interactions in molecular recognition: perspectives on pharmaceuticals and pesticides","volume":"66","author":"Liang","year":"2018","journal-title":"J. Agric. Food Chem."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34297_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.32538","article-title":"Intestinal peroxisome proliferator-activated receptor \u03b1-fatty acid-binding protein 1 axis modulates nonalcoholic steatohepatitis","volume":"77","author":"Yan","year":"2023","journal-title":"Hepatology"},{"issue":"3","key":"10.1016\/j.heliyon.2024.e34297_bib48","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/j.jhep.2014.10.039","article-title":"Molecular mechanism of PPAR\u03b1 action and its impact on lipid metabolism, inflammation and fibrosis in non-alcoholic fatty liver disease","volume":"62","author":"Pawlak","year":"2015","journal-title":"J. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154342","article-title":"Revealing the role of peroxisome proliferator-activated receptor \u03b2\/\u03b4 in nonalcoholic fatty liver disease","volume":"114","author":"Zarei","year":"2021","journal-title":"Metabolism"},{"issue":"4","key":"10.1016\/j.heliyon.2024.e34297_bib50","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1007\/s13105-017-0589-6","article-title":"PI3K inhibition protects mice from NAFLD by down-regulating CMKLR1 and NLRP3 in Kupffer cells","volume":"73","author":"Zhang","year":"2017","journal-title":"J. Physiol. Biochem."},{"key":"10.1016\/j.heliyon.2024.e34297_bib51","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1111\/nyas.12037","article-title":"Inhibition of phosphoinositide 3-kinase \u03b3 attenuates inflammation, obesity, and cardiovascular risk factors","volume":"1280","author":"Wymann","year":"2013","journal-title":"Ann. N. Y. Acad. Sci."},{"issue":"6","key":"10.1016\/j.heliyon.2024.e34297_bib52","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1002\/hep.30307","article-title":"PI3K\u03b4 is a therapeutic target in hepatocellular carcinoma","volume":"68","author":"Ko","year":"2018","journal-title":"Hepatology"},{"issue":"2","key":"10.1016\/j.heliyon.2024.e34297_bib53","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/hep.28307","article-title":"The DNAJB1\u2010PRKACA chimera: candidate biomarker and therapeutic target for fibrolamellar carcinomas","volume":"63","author":"Reid","year":"2016","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.heliyon.2024.e34297_bib54","doi-asserted-by":"crossref","first-page":"2661","DOI":"10.1111\/jcmm.17841","article-title":"Oridonin suppresses gastric cancer SGC-7901 cell proliferation by targeting the TNF-alpha\/androgen receptor\/TGF-beta signalling pathway axis","volume":"27","author":"Gao","year":"2023","journal-title":"J. Cell Mol. Med."},{"issue":"1","key":"10.1016\/j.heliyon.2024.e34297_bib55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1186\/s12885-021-08520-1","article-title":"Computational analysis for identification of early diagnostic biomarkers and prognostic biomarkers of liver cancer based on GEO and TCGA databases and studies on pathways and biological functions affecting the survival time of liver cancer","volume":"21","author":"Gao","year":"2021","journal-title":"BMC Cancer"},{"key":"10.1016\/j.heliyon.2024.e34297_bib56","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41575-020-00381-6","article-title":"Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention","volume":"18","author":"Huang","year":"2021","journal-title":"Nat. Rev. Gastroenterol. Hepatol."},{"key":"10.1016\/j.heliyon.2024.e34297_bib57","doi-asserted-by":"crossref","DOI":"10.1016\/j.saa.2023.123815","article-title":"Spectroscopy and molecular simulation on the interaction of Nano-Kaempferol prepared by oil-in-water with two carrier proteins: an investigation of protein-protein interaction","volume":"309","author":"Kaffash","year":"2024","journal-title":"Spectrochim. Acta Mol. Biomol. Spectrosc."},{"key":"10.1016\/j.heliyon.2024.e34297_bib58","article-title":"Glucokinase activity enhancement by cellulose nanocrystals isolated from jujube seed: a novel perspective for type II diabetes mellitus treatment (In vitro)","volume":"1269","author":"Hamid","year":"2022","journal-title":"J. Mol. Struct."}],"container-title":["Heliyon"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024103283?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2405844024103283?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T13:44:11Z","timestamp":1773841451000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2405844024103283"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7]]},"references-count":58,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2405844024103283"],"URL":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34297","relation":{},"ISSN":["2405-8440"],"issn-type":[{"value":"2405-8440","type":"print"}],"subject":[],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The molecular and network mechanisms of antilipidemic potential effects of Ganfule capsules in nonalcoholic fatty liver disease","name":"articletitle","label":"Article Title"},{"value":"Heliyon","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.heliyon.2024.e34297","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"e34297"}}